# Bellco Srl

- Location (FDA's records): Mirandola, IT
- FDA decisions: 3 (2016–2023): 3 510(k) clearances
- Product codes: KDI (3)
- 510(k) review time since 2016: median 263 days, against 230 for FDA's reviews in the same codes and years (1 of 3 faster)
- Predicates its devices cite: 5 (1 its own); citations of its devices by later devices: 1 (1 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Baxter Healthcare Corp: 2 (https://510kreport.com/company/baxter-healthcare)
- Gambro Renal Products: 1 (https://510kreport.com/company/gambro-renal-products)
- Gambro Renal Care Products: 1 (https://510kreport.com/company/gambro-renal-care-products)

## Its most-cited devices
- K193542: Clearum HS Family, Clearum HS Models: HS 13, HS 15, HS 17, HS 20, HS 22 (2020), cited by 1

## Recent decisions
- K231406: ClearumTM HS (Jun 14, 2023)
- K193542: Clearum HS Family, Clearum HS Models: HS 13, HS 15, HS 17, HS 20, HS 22 (Oct 8, 2020)
- K160558: Rapido Hollow-Fibre Dialyzers (Nov 18, 2016)

Source page: https://510kreport.com/company/bellco